Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.51
Delayed Data
As of Jun 29
 -0.22 / -5.90%
Today’s Change
1.13
Today|||52-Week Range
4.37
+7.01%
Year-to-Date

Today’s Trading

Previous close3.73
Today’s open3.80
Day’s range3.41 - 3.80
Volume419,925
Average volume (3 months)160,742
Market cap$167.1M
Dividend yield--
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)-269.23%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.38%
P/E ratioNM
Price/Sales44.43
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd+0.11+1.44%
DRRXDURECT Corp+0.02+1.64%
IMDZImmune Design Corp+0.01+0.12%
SNDXSyndax Pharmaceutica...+0.12+1.24%
Data as of 06/29/2016

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.8M
Annual profit (last year)-$17.9M
Net profit margin-647.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer &
Secretary
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts

Partner Offers

Search for Jobs